Vaccine Development

Nov 15, 2017
BioPharm International
Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
Nov 15, 2017
BioPharm International
This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.
Nov 15, 2017
BioPharm International
The use of therapeutic vaccines presents a new way to manage diseases, such as cancer and sexually transmitted diseases.
Nov 11, 2017
BioPharm International
This article discusses the potential of using high-productivity membrane chromatography to achieve intensified and flexible virus manufacturing.
Nov 10, 2017
By BioPharm International Editors
The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.
Nov 03, 2017
By BioPharm International Editors
The Human Vaccines Project has created the Universal Influenza Vaccine Initiative, a research program that will aim to understand the human immune system’s role in the development of universal influenza vaccines.
Oct 27, 2017
By BioPharm International Editors
The vaccine is approved for the prevention of shingles in adult patients aged 50 years and older.
Oct 26, 2017
By BioPharm International Editors
Inovio has reported results from a study with non-human primates that showed 100% effectiveness with a DNA vaccine the company is developing with the US Army.
Oct 20, 2017
By BioPharm International Editors
The companies aim to use CureVac’s proprietary messenger RNA technology to develop and commercialize up to five potential cancer vaccine products.
Oct 19, 2017
By BioPharm International Editors
The two companies announced their collaboration for the production and development of cancer vaccines.
native1_300x100
lorem ipsum